AstraZeneca Board Rejects New Offer From Pfizer

Monday, May 19, 2014

The board of directors of British drug maker AstraZeneca says it rejects the raised $119 billion takeover offer from U.S. drugmaker Pfizer.

In a statement released Monday, AstraZeneca's board said it "reiterates its confidence in AstraZeneca's ability to deliver on its prospects as an independent, science led business."

Pfizer Inc., ...


Money Talking

Why Pfizer Wants to Move to the United Kingdom

Friday, May 02, 2014

Founded 165 years ago in Brooklyn, the U.S. pharma giant wants lower taxes, and is willing to become a British company to get them.



If Pfizer Leaves NYC, Will It Start a Trend?

Thursday, May 01, 2014

If New York-based Pfizer in effect renounces its U.S. citizenship, what does that mean for the city?

Comments [3]


Direct-to-Consumer Viagra: Pharma Sale Strategy of the Future?

Tuesday, May 07, 2013

One of the world’s largest pharmaceutical companies is trying something new. Starting this week, New York-based Pfizer will sell Viagra directly to consumers, so they don’t need to get it from a pharmacy.


The Takeaway

Patent Expires For Popular Drug Lipitor

Wednesday, November 30, 2011

The 10 million Americans who take Lipitor to deal with their high cholesterol are about to get some good news. The 20 year patent on the blockbuster prescription drug expires Wednesday, creating an opening for other companies to manufacture cheaper, chemically identical generic versions of the drug. Two companies have products coming out on the market to entice the 3.5 million users of Lipitor away. But Pfizer, the makers of Lipitor − which derives almost a fifth of its revenue from $11 billion in sales of the drug — has its own plan for keeping patients on the name brand.

Comments [1]


New-York Based Pfizer to Keep Exlusive Hold on Viagra

Monday, August 15, 2011

New York-based pharmaceutical giant Pfizer will be able hold onto its blockbuster drug Viagra for several more years, a federal court judge ruled.



Pfizer to Cut 6,000 Jobs

Tuesday, May 18, 2010

New York-based drugmaker Pfizer says it will reduce its global workforce by 6,000 employees over the next several years.